Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-24-106387

Options or other derivatives

  • Chief Medical Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Janku Filip Chief Medical Officer 2024-09-13 Grant or award · Stock Option (Right to Buy) +30,000 30,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…